(11bR)-N-Benzyl-N-methyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 97.0%, 1g

2-(3,4-Dimethylphenyl)-1,3,2-dioxaborinane, 95.0%, 250mg

Methyl 3-(4-aminophenyl)propanoate hydrochloride, 98.0%, 1g

(S)-1-((1S,3aR,4S,7aR)-4-((tert-Butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)ethan-1-ol, 98%, 50mg

4,6-Dimethylnicotinic acid, 95.0%, 1g

2-(Benzofuran-5-yl)acetic Acid, 97%, 1g

1-BROMO-4-METHOXY-2,3-DINITROBENZENE, 95.0%, 1g

2H-Benzo[b][1,4]thiazin-3(4H)-one, 95.0%, 1g

4-Cyclopentene-1,3-dione, 97%, 1g

5-AZASPIRO[2.3]HEXANE HCL, 95.0%, 1g

3-Bromobenzo[b]thiophene-2-carbaldehyde, 95+%, 250mg

3-(5-ethyl-1,3,4-oxadiazol-2-yl)phenol, 95.0%, 250mg

Timidina, mínimo 99 %, pa, 5 g, envase de vidrio